Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 539

1.

Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.

Behnke K, Søgaard J, Martin S, Bäuml J, Ravindran AV, Agren H, Vester-Blokland ED.

J Clin Psychopharmacol. 2003 Aug;23(4):358-64. Erratum in: J Clin Psychopharmacol. 2003 Dec;23(6):682.

PMID:
12920411
2.

Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.

Benkert O, Szegedi A, Philipp M, Kohnen R, Heinrich C, Heukels A, van der Vegte-Senden M, Baker RA, Simmons JH, Schutte AJ.

J Clin Psychopharmacol. 2006 Feb;26(1):75-8.

PMID:
16415711
3.
4.

Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.

Guelfi JD, Ansseau M, Timmerman L, Kørsgaard S; Mirtazapine-Venlafaxine Study Group.

J Clin Psychopharmacol. 2001 Aug;21(4):425-31.

PMID:
11476127
5.

Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.

Roose SP, Nelson JC, Salzman C, Hollander SB, Rodrigues H; Mirtazapine in the Nursing Home Study Group.

Curr Med Res Opin. 2003;19(8):737-46.

PMID:
14687445
6.

Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.

Versiani M, Moreno R, Ramakers-van Moorsel CJ, Schutte AJ; Comparative Efficacy Antidepressants Study Group.

CNS Drugs. 2005;19(2):137-46.

PMID:
15697327
7.

Mirtazapine compared with paroxetine in major depression.

Benkert O, Szegedi A, Kohnen R.

J Clin Psychiatry. 2000 Sep;61(9):656-63.

PMID:
11030486
8.

Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.

Thase ME, Nierenberg AA, Vrijland P, van Oers HJ, Schutte AJ, Simmons JH.

Int Clin Psychopharmacol. 2010 Jul;25(4):189-98. doi: 10.1097/YIC.0b013e328330adb2.

PMID:
20531012
9.
10.

Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data.

Kasper S.

Int Clin Psychopharmacol. 1995 Dec;10 Suppl 4:25-35. Review. Erratum in: Int Clin Psychopharmacol 1996 Jun;11(2):153.

PMID:
8930007
11.

Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.

Fava M, Dunner DL, Greist JH, Preskorn SH, Trivedi MH, Zajecka J, Cohen M.

J Clin Psychiatry. 2001 Jun;62(6):413-20.

PMID:
11465517
12.

Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.

Schatzberg AF, Kremer C, Rodrigues HE, Murphy GM Jr; Mirtazapine vs. Paroxetine Study Group.

Am J Geriatr Psychiatry. 2002 Sep-Oct;10(5):541-50.

PMID:
12213688
13.
14.
15.

Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.

van Moffaert M, de Wilde J, Vereecken A, Dierick M, Evrard JL, Wilmotte J, Mendlewicz J.

Int Clin Psychopharmacol. 1995 Mar;10(1):3-9.

PMID:
7622801
16.

Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.

Leinonen E, Lepola U, Koponen H, Mehtonen OP, Rimon R.

Acta Psychiatr Scand. 1997 Dec;96(6):497-504.

PMID:
9421348
17.

Efficacy, tolerability, and preference of mirtazapine orally disintegrating tablets in depressed patients: a 17-week naturalistic study in Lithuania.

Danileviciūte V, Sveikata A, Adomaitiene V, Gumbrevicius G, Fokas V, Sveikatiene R.

Medicina (Kaunas). 2009;45(10):778-84.

19.

Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.

Malhi GS, Ng F, Berk M.

Aust N Z J Psychiatry. 2008 Apr;42(4):346-9. doi: 10.1080/00048670701881587.

PMID:
18330778
20.

Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial.

Chung MY, Min KH, Jun YJ, Kim SS, Kim WC, Jun EM.

Hum Psychopharmacol. 2004 Oct;19(7):489-94.

PMID:
15378676

Supplemental Content

Support Center